Skip to main content
Premium Trial:

Request an Annual Quote

NY State Grants Clinical Lab Permit to Agendia

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Amsterdam-based Agendia said today that New York regulators have granted the firm a clinical laboratory permit, enabling it to receive commercial samples for its MammaPrint breast cancer recurrence assay from NY state residents.

The company said that with the latest permit from the New York State Department of Health, it has all major US clinical laboratory licenses. The firm's MammaPrint test, which is a multivariate index assay, received marketing clearance from the US Food and Drug Administration three years ago.

Agendia also said that the College of American Pathologists has accredited the firm's lab in Huntington Beach, Calif.

"The growing clinical importance of complex genomic testing means that our laboratories need to meet the highest standards of quality for patients and health care professionals," Agendia CEO Bernhard Sixt said in a statement, adding that the permit from New York is "recognized as the most difficult to obtain."

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.